AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net buying: insiders sold $1.1M and bought $1.7M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$615K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $37.38
- 52-wk high
- $72.66
- High
- $37.53
- 52-wk low
- $36.07
- Low
- $36.71
- Prev close
- $37.25
- Mkt cap
- $3.61B
- Volume
- 2.47M
- Beta
- 0.62
- P/S
- 727.4x
- P/B
- 3.0x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -43.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about XENE filings
Are insiders buying or selling Xenon Pharmaceuticals Inc (XENE) stock?
Net buying: insiders sold $1.1M and bought $1.7M of XENE stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. $426K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Mortimer, Ian (President & CEO), who bought $1.1M. The latest filing was on Oct 1, 2026.
Which members of Congress have traded XENE recently?
None. No member of Congress disclosed a XENE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this XENE smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- TS
Two Sigma
$63.9M
added
- MW
Marshall Wace
$41.6M
bought
- BO
Bank of America
$9.0M
added
What insiders are doing
Buys (2)
- MI
Mortimer Ian
$1.1M
bought
- KT
Kelly Thomas Patrick
$560K
bought
Sells (1)
- KC
Kenney Christopher John
$426K
sold
How top traders are positioned
No tracked top-trader positions in XENE right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 4.3% above what analysts expected.
Earnings per share
-$1.16 expected
Reports Nov 2, 2026, in 32 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $3.6B
Valuation
- P/S727.44
- P/B3.04
Quality
- Operating margin0.0%
- ROE-43.6%
- ROA-28.0%
Growth
- Beta0.62
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace